Skip to content

Optical genome mapping in addition to cytogenetic characterization based on apparently balanced chromosome translocations

Optical genome mapping in addition to cytogenetic characterization based on apparently balanced chromosome translocations

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00026087
Enrollment
5
Registered
2021-08-13
Start date
2021-08-06
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Q99.9

Interventions

Group 1: Further investigations are carried out on the blood of patients from the human genetic counseling who have chromosome aberrations balanced at the cytogenetic level.

Sponsors

Universitätsklinikum FreiburgInstitut für Humangenetik
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: apparently balanced chromosome translocations

Exclusion criteria

Exclusion criteria: inconspicuous set of chromosomes

Design outcomes

Primary

MeasureTime frame
The primary goal of the project and the further investigations is to clarify the previously unexplained cases with a genomic aberration regarding to the clinical abnormalities of the patients. In addition to conventional cytogenetic and molecular cytogenetic methods, the secondary aim is to evaluate and integrate optical genome mapping into routine diagnostics.

Secondary

MeasureTime frame
By comparing and expanding methodological approaches, various diagnostic options are to be discussed. The aim is to achieve a long-term benefit for the affected patients concerning a clear diagnosis and subsequent therapy.

Countries

Germany

Contacts

Public ContactJudith Fischer

Institut für Humangenetik FreiburgUniversitätsklinikum Freiburg

judith.fischer@uniklinik-freiburg.de0761/27070510

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026